Adaptimmune Therapeutics PLC
(NASDAQ:ADAP)
$0.519
0.0209[4.20%]
Last update: 6:17PM (Delayed 15-Minutes)
Get Real Time Here
$0.519
0[0.00%]
After-Hours
Open0.490Close0.500
Vol / Avg.221.673K / 415.654KMkt Cap117.876M
Day Range0.471 - 0.51652 Wk Range0.420 - 2.380

Adaptimmune Therapeutics Stock (NASDAQ:ADAP) Dividends: History, Yield and Dates

Historical and Upcoming Adaptimmune Therapeutics Dividends

The dividend schedule below includes dividend amounts, payment dates and ex-dividend dates for Adaptimmune Therapeutics. Adaptimmune Therapeutics issues dividends to shareholders from excess cash the company generates. Most companies pay dividends on a quarterly basis, but dividends may also be paid monthly, annually or at irregular intervals.

No data available to display
Ex-Date
▲▼
ticker
▲▼
Company
▲▼
Payments per year
▲▼
Dividend
▲▼
Yield
▲▼
Announced
▲▼
Record
▲▼
Payable
▲▼
Get Alert
Q

When does Adaptimmune Therapeutics (ADAP) pay its next dividend?

A

There are no upcoming dividends for Adaptimmune Therapeutics.

Q

What date did I need to own Adaptimmune Therapeutics (ADAP) stock to get the latest dividend?

A

There are no upcoming dividends for Adaptimmune Therapeutics.

Q

How much per share is the next Adaptimmune Therapeutics (ADAP) dividend?

A

There are no upcoming dividends for Adaptimmune Therapeutics.

Q

What is the dividend yield for Adaptimmune Therapeutics (NASDAQ:ADAP)?

A

There are no upcoming dividends for Adaptimmune Therapeutics.

Q

What was the announcement date for the next Adaptimmune Therapeutics (ADAP) dividend?

A

There are no upcoming dividends announced for Adaptimmune Therapeutics.

Q

Why is Adaptimmune Therapeutics (ADAP) dividend considered low?

A

There are no upcoming dividends announced for Adaptimmune Therapeutics.

Q

Is Adaptimmune Therapeutics (ADAP) a good dividend?

A

There is not enough data to provide an evaluation.

Q

Is the Adaptimmune Therapeutics (ADAP) dividend sustainable?

A

There is not enough data to provide an evaluation.

Browse dividends on all stocks.